Inhibition of human leucocyte elastase by ursolic acid. Evidence for a binding site for pentacyclic triterpenes.
Several pentacyclic triterpenoid metabolites of plant origin are inhibitors of hydrolysis of both synthetic peptide substrates and elastin by human leucocyte elastase (HLE). Ursolic acid, the most potent of these compounds, has an inhibition constant of 4-6 microM for hydrolysis of peptide substrates in phosphate-buffered saline. With tripeptide and tetrapeptide substrates, the inhibition is purely competitive, whereas with a shorter dipeptide substrate the inhibition is non-competitive, suggesting that ursolic acid interacts with subsite S3 of the extended substrate-binding domain in HLE, but not with subsites S1 and S2. The carboxy group at position 28 in the pentacyclic-ring system of the triterpenes contributes to binding to HLE, since replacement of this group with a hydroxy group, as in uvaol, the alcohol analogue of ursolic acid, reduces the potency of inhibition. The inhibitory potency of ursolic acid is also reduced by addition of 1 M-NaCl, further supporting a postulated electrostatic interaction between the negative charge on the triterpene and a positively charged residue on the enzyme, which we assign to the side chain of Arg-217, located in the vicinity of subsites S4 and S5 in HLE. These observations are consistent with a binding site for ursolic acid which extends from S3 towards S4 and S5 on the enzyme. Other triterpenes, including oleanolic acid, erythrodiol, hederagenin and 18 beta-glycyrrhetic acid, can also interact with this binding site. On the basis of these results we conclude that the extended substrate-binding domain of HLE can accommodate a variety of hydrophobic ligands, including not only such molecules as fatty acids [Ashe & Zimmerman (1977) Biochem. Biophys. Res. Commun. 75, 194-199; Cook & Ternai (1988) Biol. Chem. Hoppe-Seyler 369, 629-637], but also polycyclic molecules such as the pentacyclic triterpenoids.
Ying
Q L
QL
Department of Pathology, State University of New York, Stony Brook 11794.
Rinehart
A R
AR
Simon
S R
SR
Cheronis
J C
JC
D000595:Amino Acid Sequence; D000890:Anti-Infective Agents / Q000494:pharmacology; D001665:Binding Sites; D004549:Elastin / Q000378:metabolism; D007700:Kinetics; D019272:Leukocyte Elastase; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009842:Oligopeptides / Q000138:chemical synthesis; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors*; D013379:Substrate Specificity; D014315:Triterpenes / Q000378:metabolism* / Q000494:pharmacology*; D000097245:Ursolic Acid
D000890:Anti-Infective Agents; D004549:Elastin; D019272:Leukocyte Elastase; D009842:Oligopeptides; D010196:Pancreatic Elastase; D014315:Triterpenes; D000097245:Ursolic Acid